No abstract available
Keywords:
adalimumab; antirheumatic agents; arthritis; biological therapy; rheumatoid; tumor necrosis factor inhibitors.
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adalimumab / therapeutic use*
-
Age Factors
-
Aged
-
Antirheumatic Agents / therapeutic use*
-
Arthritis, Rheumatoid / drug therapy*
-
Biological Products / therapeutic use
-
Female
-
Humans
-
Incidence
-
Infections / epidemiology*
-
Janus Kinase Inhibitors / therapeutic use*
-
Male
-
Middle Aged
-
Piperidines / therapeutic use*
-
Proportional Hazards Models
-
Pyrimidines / therapeutic use*
-
Registries*
-
Risk Factors
-
United States / epidemiology
Substances
-
Antirheumatic Agents
-
Biological Products
-
Janus Kinase Inhibitors
-
Piperidines
-
Pyrimidines
-
tofacitinib
-
Adalimumab